[{"bbox": [91, 99, 368, 131], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [95, 171, 726, 201], "category": "List-item", "text": "9) Scrutiny of inter-corporate loans and investments;"}, {"bbox": [95, 203, 1044, 233], "category": "List-item", "text": "10) Valuation of undertakings or assets of the Company, wherever it is necessary;"}, {"bbox": [95, 235, 970, 265], "category": "List-item", "text": "11) Evaluation of internal financial controls and risk management systems;"}, {"bbox": [156, 267, 1443, 298], "category": "List-item", "text": "a. Establishing a vigil mechanism for directors and employees to report their genuine concerns or grievances;"}, {"bbox": [95, 300, 1556, 361], "category": "List-item", "text": "12) Reviewing, with the management, the performance of statutory and internal auditors, and adequacy of the internal control systems;"}, {"bbox": [95, 363, 1556, 425], "category": "List-item", "text": "13) Reviewing the adequacy of internal audit function if any, including the structure of the internal audit department, staffing and seniority of the official heading the department, reporting structure coverage and frequency of internal audit;"}, {"bbox": [95, 427, 1118, 457], "category": "List-item", "text": "14) Discussing with internal auditors on any significant findings and follow up thereon;"}, {"bbox": [95, 459, 1556, 521], "category": "List-item", "text": "15) Reviewing the findings of any internal investigations by the internal auditors into matters where there is suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting the matter to the Board;"}, {"bbox": [95, 523, 1558, 584], "category": "List-item", "text": "16) Discussing with statutory auditors before the audit commences, about the nature and scope of audit as well as post-audit discussion to ascertain any area of concern;"}, {"bbox": [95, 586, 1556, 648], "category": "List-item", "text": "17) Looking into the reasons for substantial defaults in the payment to the depositors, debenture holders, shareholders (in case of non-payment of declared dividends) and creditors;"}, {"bbox": [95, 650, 856, 680], "category": "List-item", "text": "18) Reviewing the functioning of the whistle blower mechanism;"}, {"bbox": [95, 682, 1556, 743], "category": "List-item", "text": "19) Approving the appointment of the chief financial officer or any other person heading the finance function or discharging that function after assessing the qualifications, experience and background, etc. of the candidate;"}, {"bbox": [95, 745, 1556, 839], "category": "List-item", "text": "20) Reviewing the utilization of loans and/ or advances from/investment by the holding company in any subsidiary exceeding â‚¹1,000 million or 10% of the asset size of the subsidiary, whichever is lower including existing loans / advances / investments;"}, {"bbox": [95, 841, 1556, 903], "category": "List-item", "text": "21) Considering and commenting on the rationale, cost-benefits and impact of schemes involving merger, demerger, amalgamation etc., on the Company and its shareholders;"}, {"bbox": [95, 905, 1556, 967], "category": "List-item", "text": "22) Such roles as may be delegated by the Board and/or prescribed under the Companies Act, 2013 and SEBI Listing Regulations or other applicable law; and"}, {"bbox": [95, 969, 1556, 1032], "category": "List-item", "text": "23) Carrying out any other functions as is mentioned in the terms of reference of the audit committee or containing into SEBI (LODR) Regulations 2015."}, {"bbox": [95, 1064, 1048, 1094], "category": "Text", "text": "Further, the Audit Committee shall mandatorily review the following information:"}, {"bbox": [95, 1128, 1123, 1159], "category": "List-item", "text": "1) management discussion and analysis of financial condition and results of operations;"}, {"bbox": [95, 1161, 1439, 1191], "category": "List-item", "text": "2) statement of significant related party transactions (as defined by the audit committee), submitted by management;"}, {"bbox": [95, 1193, 1193, 1223], "category": "List-item", "text": "3) management letters / letters of internal control weaknesses issued by the statutory auditors;"}, {"bbox": [95, 1225, 846, 1255], "category": "List-item", "text": "4) internal audit reports relating to internal control weaknesses;"}, {"bbox": [95, 1257, 1558, 1318], "category": "List-item", "text": "5) the appointment, removal and terms of remuneration of the chief internal auditor shall be subject to review by the audit committee; and"}, {"bbox": [95, 1320, 418, 1350], "category": "List-item", "text": "6) statement of deviations:"}, {"bbox": [144, 1352, 1558, 1415], "category": "List-item", "text": "a. quarterly statement of deviation(s) including report of monitoring agency, if applicable, submitted to stock exchange(s) in terms of Regulation 32(1) of the SEBI ICDR Regulations;"}, {"bbox": [144, 1417, 1558, 1479], "category": "List-item", "text": "b. annual statement of funds utilized for purposes other than those stated in the offer document/prospectus/notice in terms of Regulation 32(7) of the SEBI ICDR Regulations."}, {"bbox": [119, 1511, 640, 1543], "category": "Section-header", "text": "## 2. Stakeholders Relationship Committee"}, {"bbox": [91, 1575, 1558, 1703], "category": "Text", "text": "Our Company has formed the Stakeholders Relationship Committee as per the applicable provisions of the Section 178(5) and other applicable provisions of the Companies Act, 2013 read with Rule 6 of the Companies (Meetings of Board and its Powers) Rules, 2014 and Regulation 20 of SEBI Listing Regulation, 2015 vide Resolution dated September 27, 2025. The constituted Stakeholders Relationship Committee comprises the following:"}, {"bbox": [91, 1731, 1558, 1900], "category": "Table", "text": "<table><thead><tr><td>Name of the Director</td><td>Status in Committee</td><td>Nature of Directorship</td></tr></thead><tbody><tr><td>Abhishek Mishra</td><td>Chairman</td><td>Independent Director</td></tr><tr><td>Kuldeep Chowdhry</td><td>Member</td><td>Whole Time Director</td></tr><tr><td>Yethadka Subraya Prabhakara</td><td>Member</td><td>Whole Time Director</td></tr></tbody></table>"}, {"bbox": [91, 1934, 1558, 1997], "category": "Text", "text": "The Company Secretary of our Company shall act as a Secretary to the Stakeholders Relationship Committee. The scope and function of the Stakeholders Relationship Committee and its terms of reference shall include the following:"}, {"bbox": [91, 2029, 1558, 2123], "category": "List-item", "text": "A. Tenure: The Stakeholders Relationship Committee shall continue to be in function as a committee of the Board until otherwise resolved by the Board, to carry out the functions of the Stakeholders Relationship Committee as approved by the Board."}, {"bbox": [804, 2171, 848, 2200], "category": "Page-footer", "text": "164"}]